Join the SDRC

The SDRC is open to everyone who is taking part in or interested in dementia and brain health research in Scotland. Anyone from anywhere is free to join the SDRC, whether you are a researcher in Scotland or not.

There are many benefits to being an SDRC member. These include:

  • Invitations to attend members only events to discuss dementia research
  • Linking and networking with other members
  • Opportunities to showcase your research or current work projects
  • Gain career advice from world leading dementia research experts

When you join the SDRC, you will receive updates on SDRC activity, our monthly newsletter and exclusive or early access to SDRC events. You will also be able to communicate with other SDRC members to promote your research and will be invited to write blogs or articles for the SDRC website and Twitter 

In the application we ask you which SDRC Theme (s) are of most interest to you. This is so we can tailor our communications to the types of research you find most relevant.

Membership is free! To join our community of over 1000 members, please fill in the form below.

Subscribe

* indicates required
Are you a early career researcher or PhD student?
Are you directly involved in research?
What SDRC Theme(s) are most relevant to you?

Read SDRC Latest

SDRC Support for Early Career Researchers

The SDRC aim to be here for all dementia researchers based in Scotland. Of course, supporting ECRs is a key part of this, and we want to do all we can to nurture emerging talent and help develop the future leaders in dementia and brain health research. As was part of...

Research in the News: Football Heading and Dementia Risk

Researchers Glasgow Brain Injury Research Group (GBIRG) led by Associate Professor Willie Stewart, have published their findings reporting a link between a footballers' outfield position and neurodegenerative risk.  Taking place at the University of Glasgow, as part...

Research Strategy Oversight Board Chair: Henry McLeish

The Scottish Dementia Research Consortium, Brain Health Scotland and Alzheimer Scotland are delighted to announce the appointment of Henry McLeish as the Chair of the Scottish Brain Health and Dementia Research Strategy Oversight Board.  In July 2021, the SDRC,...

SDRC Executive Committee Member: Dr Jennifer Macfarlane

In October 2022, the SDRC held our election to refresh the Executive Committee. We are now able to announce who was successfully voted. Jennifer Macfarlane has been a co-opted member of the SDRC Executive Committee since earlier this year, we are now delighted to...

Alzheimer Scotland Student Research Programme: Award Announcement

The Alzheimer Scotland Student Research Programme has funded two projects during its 2023/4 round of applications. We are pleased to announce the team that were awarded the second of two awards is Dr Coco Newton from University College London and Prof Anja Maier from...

The launch of the SDRC Annual Report 2022/23

The SDRC Annual Report 2023, launched at the SDRC Annual Conference on Tuesday 25th April 2023. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. It includes the updates from each of the SDRC Research...

Scottish Neurological Research Fund 2024/5: Award Announcement

We have produced a report based on the findings of how COVID-19 has impacted our members’ research- with particular focus on ECRs

New SDRC Executive Committee Member: Dr Leah Macaden

Following the 2022 SDRC Executive Committee election, Dr Leah Macaden has been elected as a new member. Find out more in Leah's biography below. Dr Leah Macaden is a Senior Lecturer in Nursing at the University of Edinburgh with a rich and diverse range of academic,...

Call for new members: Scottish Cognitive Ageing Network

The Scottish Cognitive Ageing Network (SCAN) was established in 2022, aimed at formalising and building on cross-institutional links in cognitive ageing research across Scotland. The inaugural meeting took place at the University of Strathclyde in May, with a second...

Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Dr Terry Quinn explains approval of new Alzheimer's disease drug  SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the treatment of...